Irinotecan and Carboplatin (IC) Regimen for Lung Cancer

J. Aubrey Waddell; Dominic A. Solimando

doi:10.1310/hpj4409-740

Abstract

The complexity of cancer chemotherapy requires that pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and investigational, used to treat malignant diseases.

Authors

J. Aubrey Waddell#1 Dominic A. Solimando#2

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

unpaywall

Confidence 95%

datacite

Confidence 0%

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

10.1038/sj.bjc.6603079

10.1016/j.lungcan.2007.03.001

10.1016/s0169-5002(02)00073-9

10.1016/s0169-5002(03)00075-8

10.1093/annonc/mdj137

10.1016/j.lungcan.2006.08.014

10.1200/jco.2007.15.7545

10.1200/jco.2008.20.2127

10.1007/s00280-004-0805-2

10.1016/s1556-0864(15)31629-4

Unresolved referenced work

Kept as external metadata until matched